GR3031303T3 - Method for quantifying lbp in body fluids - Google Patents

Method for quantifying lbp in body fluids

Info

Publication number
GR3031303T3
GR3031303T3 GR990402403T GR990402403T GR3031303T3 GR 3031303 T3 GR3031303 T3 GR 3031303T3 GR 990402403 T GR990402403 T GR 990402403T GR 990402403 T GR990402403 T GR 990402403T GR 3031303 T3 GR3031303 T3 GR 3031303T3
Authority
GR
Greece
Prior art keywords
body fluids
lbp
quantifying
quantifying lbp
subject
Prior art date
Application number
GR990402403T
Other languages
English (en)
Inventor
Mark Leslie White
Stephen Fitzhugh Carroll
Jeremy Kam-Kuen Ma
Original Assignee
Xoma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xoma Corp filed Critical Xoma Corp
Publication of GR3031303T3 publication Critical patent/GR3031303T3/el

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/821—Chemistry: analytical and immunological testing involving complement factors or complement systems

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Peptides Or Proteins (AREA)
GR990402403T 1994-01-24 1999-09-22 Method for quantifying lbp in body fluids GR3031303T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/186,811 US5484705A (en) 1994-01-24 1994-01-24 Method for quantifying lipopolysaccharide binding protein
PCT/US1995/000982 WO1995020163A1 (en) 1994-01-24 1995-01-24 Method for quantifying lbp in body fluids

Publications (1)

Publication Number Publication Date
GR3031303T3 true GR3031303T3 (en) 1999-12-31

Family

ID=22686373

Family Applications (1)

Application Number Title Priority Date Filing Date
GR990402403T GR3031303T3 (en) 1994-01-24 1999-09-22 Method for quantifying lbp in body fluids

Country Status (13)

Country Link
US (3) US5484705A (el)
EP (1) EP0741870B1 (el)
JP (1) JP3554331B2 (el)
CN (1) CN1132013C (el)
AT (1) ATE182216T1 (el)
AU (1) AU701710B2 (el)
DE (1) DE69510772T2 (el)
DK (1) DK0741870T3 (el)
ES (1) ES2133738T3 (el)
GR (1) GR3031303T3 (el)
HK (1) HK1015174A1 (el)
MX (1) MX9602688A (el)
WO (1) WO1995020163A1 (el)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652332A (en) * 1993-03-12 1997-07-29 Xoma Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
US5484705A (en) * 1994-01-24 1996-01-16 Xoma Corporation Method for quantifying lipopolysaccharide binding protein
US5891618A (en) * 1994-01-24 1999-04-06 Xoma Corporation Method for quantifying LBP in body fluids
US5932536A (en) * 1994-06-14 1999-08-03 The Rockefeller University Compositions for neutralization of lipopolysaccharides
AU727085B2 (en) * 1995-07-20 2000-11-30 Xoma Corporation Anti-fungal peptides
AU735058B2 (en) * 1996-05-10 2001-06-28 Xoma Corporation Therapeutic uses of BPI protein products for human meningococcemia
ATE234111T1 (de) * 1996-05-23 2003-03-15 Xoma Technology Ltd Therapeutische verwendungen von bpi-protein produkten bei menschen mit durch trauma verursachter blutung
US5888973A (en) 1996-08-09 1999-03-30 Xoma Corporation Anti-chlamydial uses of BPI protein products
US6482796B2 (en) 1996-11-01 2002-11-19 Xoma Corporation Therapeutic uses of N-terminal BPI protein products in ANCA-positive patients
US6093573A (en) * 1997-06-20 2000-07-25 Xoma Three-dimensional structure of bactericidal/permeability-increasing protein (BPI)
US5990082A (en) * 1997-10-22 1999-11-23 Xoma Corporation Uses of lipopolysaccharide binding protein
US6013631A (en) * 1998-06-19 2000-01-11 Xoma Corporation Bactericidal/permeability-increasing protein (BPI) deletion analogs
US7465555B2 (en) * 2002-04-02 2008-12-16 Becton, Dickinson And Company Early detection of sepsis
MXPA05005031A (es) * 2002-11-12 2005-11-17 Becton Dickinson Co Diagnostico de la sepsis o sirs usando perfiles de biomarcadores.
CA2505843A1 (en) * 2002-11-12 2004-05-27 Becton, Dickinson And Company Diagnosis of sepsis or sirs using biomarker profiles
MXPA05005073A (es) * 2002-11-12 2005-11-17 Becton Dickinson Co Diagnostico de la sepsis o sirs usando perfiles de biomarcadores.
US8068990B2 (en) * 2003-03-25 2011-11-29 Hologic, Inc. Diagnosis of intra-uterine infection by proteomic analysis of cervical-vaginal fluids
US7191068B2 (en) * 2003-03-25 2007-03-13 Proteogenix, Inc. Proteomic analysis of biological fluids
US20060157647A1 (en) * 2005-01-18 2006-07-20 Becton, Dickinson And Company Multidimensional liquid chromatography/spectrometry
CA2605143A1 (en) 2005-04-15 2006-10-26 Becton, Dickinson And Company Diagnosis of sepsis
NZ581442A (en) * 2007-04-26 2012-09-28 Adept Technology Inc Vacuum gripper with a flexible hood that includes a number of channel fingers
WO2009123737A2 (en) 2008-04-03 2009-10-08 Becton, Dickinson And Company Advanced detection of sepsis
US7846678B2 (en) * 2008-08-18 2010-12-07 BioDtech, Inc. Enhancing endotoxin detection
JP5674664B2 (ja) * 2008-09-04 2015-02-25 ベックマン コールター， インコーポレイテッド パンキナーゼ活性化およびシグナリング経路の評価
CN104407156B (zh) * 2014-12-05 2016-03-16 重庆中元生物技术有限公司 检测多糖结合蛋白(lbp)的胶乳增强免疫比浊试剂盒及其制备方法
CN109507323A (zh) * 2018-12-07 2019-03-22 上海浩港生物技术有限公司 一种用质谱仪检测人类血液中lbp含量的试剂盒
CN109507127A (zh) * 2018-12-07 2019-03-22 上海浩港生物技术有限公司 一种用于检测人类血液中lbp含量的试剂盒

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5245013A (en) * 1985-04-30 1993-09-14 Richard Ulevitch Acute phase protein modulating endotoxic activity of lipopolysaccharides, assay methods and polypeptides
US5310879A (en) * 1985-04-30 1994-05-10 The Scripps Research Institute Antibodies which immunoreact with lapine lipopolysaccharide binding protein (LBP)
WO1986006279A1 (en) * 1985-04-30 1986-11-06 Scripps Clinic And Research Foundation Acute phase protein modulating endotoxic activity of lipopolysaccharides, compositions and methods
JP2744130B2 (ja) * 1989-08-01 1998-04-28 スクリップス クリニック アンド リサーチ ファウンデーション 敗血症治療用組成物
WO1993006228A1 (en) * 1991-09-26 1993-04-01 Incyte Pharmaceuticals, Inc. A new form of liposaccharide binding protein (lbp)
AU6522794A (en) * 1993-03-22 1994-10-11 Incyte Pharmaceuticals, Inc. Use of bactericidal/permeability increasing protein and lipopolysaccharide binding protein levels and ratios thereof in diagnosis
CA2161971A1 (en) * 1993-04-30 1994-11-10 Randal W. Scott Recombinant bpi-based and lbp-based proteins, nucleic acid molecules encoding same, methods of producing same, and uses thereof
AU7175694A (en) * 1993-06-17 1995-01-17 Xoma Corporation Lipopolysaccharide binding protein derivatives
AU7330994A (en) * 1993-07-14 1995-02-13 Xoma Corporation Method for potentiating bpi protein product bactericidal activity by administration of lbp protein products
US5484705A (en) * 1994-01-24 1996-01-16 Xoma Corporation Method for quantifying lipopolysaccharide binding protein

Also Published As

Publication number Publication date
US6274328B1 (en) 2001-08-14
EP0741870B1 (en) 1999-07-14
DK0741870T3 (da) 1999-12-13
AU701710B2 (en) 1999-02-04
JP3554331B2 (ja) 2004-08-18
US5484705A (en) 1996-01-16
CN1139485A (zh) 1997-01-01
CN1132013C (zh) 2003-12-24
ES2133738T3 (es) 1999-09-16
ATE182216T1 (de) 1999-07-15
DE69510772D1 (de) 1999-08-19
WO1995020163A1 (en) 1995-07-27
US5804367A (en) 1998-09-08
MX9602688A (es) 1997-05-31
DE69510772T2 (de) 1999-11-11
HK1015174A1 (en) 1999-10-08
JPH09508465A (ja) 1997-08-26
EP0741870A1 (en) 1996-11-13
AU1732195A (en) 1995-08-08

Similar Documents

Publication Publication Date Title
GR3031303T3 (en) Method for quantifying lbp in body fluids
EP0987550A3 (en) Analytical test device and method of use
ATE176870T1 (de) Sammelsystem für körperflüssigkeiten eines patienten
EP0637750A3 (de) Verfahren zur Analyse von Probenflüssigkeiten.
SE9404250L (sv) Affinitetsseparationsmetod
AU4410899A (en) Stored value transaction system including an integrated database server
EP2284813A3 (en) Electronic funds transfers-zipfund
DE69626683T2 (de) Verfahren zur feststellung von antipolymerantikörper und diagnosetestsatz zur feststellung von siliconabhängigen krankheiten
HK1014207A1 (en) Method for quantifying extracellular bpi in body fluids
AU8218591A (en) Method for reducing interference in a fluorescent assay
ES2162652T3 (es) Procedimiento para la caracterizacion de la glicosilacion de glicoproteinas, asi como para la determinacion in vitro de la biodisponibilidad de glicoproteinas.
EP0911862A3 (en) Apparatus and method for microwave plasma process
WO2000031263A3 (en) Gtpase associated proteins
CA2181815A1 (en) Method for quantifying lbp in body fluids
WO2000003005A3 (en) Human checkpoint kinase
WO2000003015A3 (en) Human transport protein homologs
EA199700449A1 (ru) Способ предотвращения остеопороза
WO1999049037A3 (en) Protein phosphatase-related molecules
EP0563244A4 (en) Human phospholipase activating protein and methods for diagnosis of rheumatoid arthritis
WO1998057986A3 (en) Human preprotachykinin b
WO2002040859A3 (en) System and method for generating a right torsion field
WO2000015799A3 (en) Rna-associated proteins
ES2172214T3 (es) Procedimiento de identificacion de una imagen o de un documento.
WO2000011171A3 (en) Human rna-associated proteins
IL122426A0 (en) Method of identifying persons susceptible to neuropsychiatric disorders